English
Insider transactions
EDGARBioNexus Gene Lab Corp.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-21.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–5 of 5
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 Filed 2026-08-14 | Bin Abdul Hamid Muhammad Azrul Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 32,258 | — | — | 32,258 | Direct (D) | No | F1
| Open filing 0001520138-26-000347 Read from the filing’s XML Dispute this row |
| 2026-08-13 Filed 2026-08-14 | Chong Set Fui Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 96,774 | — | — | 96,774 | Direct (D) | No | F1
| Open filing 0001520138-26-000346 Read from the filing’s XML Dispute this row |
| 2026-08-13 Filed 2026-08-14 | Tan Lee Su-Leng Director · Officer: Chief Executive Officer · 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 338,709 | — | — | 338,709 | Direct (D) | No | F1
| Open filing 0001520138-26-000349 Read from the filing’s XML Dispute this row |
| 2026-08-13 Filed 2026-08-14 | Yap Chee Keong Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 32,258 | — | — | 32,258 | Direct (D) | No | F1
| Open filing 0001520138-26-000348 Read from the filing’s XML Dispute this row |
| 2026-08-13 Filed 2026-08-14 | Low Jook Yuen Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 16,129 | — | — | 17,390 | Direct (D) | No | F1
| Open filing 0001520138-26-000345 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.
Showing 1–4 of 4
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| UBS Group AG Partly reported under another manager | 306 SH | 373 dollars | Higher by 205 Prior quarter: 101 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| Caitong International Asset Management Co., Ltd | 137 SH | 167 dollars | Higher by 136 Prior quarter: 1 | Open filing 0001628280-26-068135 Filed 2026-10-29 Dispute this row |
| Tower Research Capital LLC (TRC) Partly reported under another manager | 12 SH | 15 dollars | Not in the prior quarter’s filings read | Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 2 SH | 3 dollars | Not in the prior quarter’s filings read | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- HRT FINANCIAL LP 14,283 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Tan Lee Su-Leng Common Stock, no par value | 11.5 | 338,709.00 | 08/13/2026 Filed 2026-08-14 | SCHEDULE 13D | Open filing 0001520138-26-000354 Dispute this row |
| Fidelion Diagnostics Pte. Ltd. COMMON STOCK, NO PAR VALUE | 13.4 | 392,329.00 | 11/28/2025 Filed 2026-10-22 | SCHEDULE 13G | Open filing 0001520138-26-000439 Dispute this row |
| MOLECULE BIO LLC COMMON STOCK, NO PAR VALUE | 13.4 | 392,329.00 | 11/28/2025 Filed 2026-10-22 | SCHEDULE 13G | Open filing 0001520138-26-000439 Dispute this row |
| XIAO LING COMMON STOCK, NO PAR VALUE | 13.4 | 392,329.00 | 11/28/2025 Filed 2026-10-22 | SCHEDULE 13G | Open filing 0001520138-26-000439 Dispute this row |
| RAINY MORNING TECHNOLOGY (HONG KONG) LIMITED COMMON STOCK, NO PAR VALUE | 13.4 | 392,329.00 | 11/28/2025 Filed 2026-10-22 | SCHEDULE 13G | Open filing 0001520138-26-000439 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,715,586 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 131,968 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,828 |
Filings made before the SEC required XML are listed, not extracted.